•
Jun 30, 2013

Ironwood Pharmaceuticals Q2 2013 Earnings Report

Total Revenue
$9.66M
Previous year: $14.6M
-33.8%
EPS
-$0.57
Previous year: -$0.38
+50.0%
Gross Profit
$6.25M
Previous year: $14.6M
-57.2%
Cash and Equivalents
$219M
Previous year: $87.1M
+152.0%
Free Cash Flow
-$82.1M
Previous year: -$45.5M
+80.4%
Total Assets
$384M
Previous year: $209M
+84.0%

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals